目錄:MedChemExpress LLC>>信號(hào)通路>> ABT-737 | MedChemExpress
CAS | 852808-04-9 | 純度 | 99.96% |
---|---|---|---|
分子量 | 813.43 | 分子式 | C??H??ClN?O?S? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mM * 1 mL |
貨號(hào) | HY-50907 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
CAS No. : 852808-04-9
MCE 國際站:ABT-737
產(chǎn)品活性:ABT-737 是一種 BH3 模擬物,是一種有效的 Bcl-2、Bcl-xL 和 Bcl-w 抑制劑,EC50 分別為 30.3 nM、78.7 nM 和 197.8 nM。ABT-737 誘導(dǎo) BCL-2/BAX 復(fù)合物的破壞和 BAK 依賴性但不依賴 BIM 的內(nèi)在凋亡途徑激活。ABT-737 誘導(dǎo)自噬,并且具有用于急性髓系白血病 (AML) 研究的潛力。
研究領(lǐng)域:Apoptosis | Autophagy
作用靶點(diǎn):Bcl-2 Family | Apoptosis | Autophagy | Mitophagy
In Vitro: ABT-737 binds BCL-2, BCL-XL, and BCL-W with high affinity (Ki<1 nM) but binds weakly (Ki>460 nM) to other antiapoptotic BCL-2 family members, including MCL-1 and BFL-1. ABT-737 binds the BH3-binding groove of BCL-XL and BCL-2.
ABT-737 (100 nM; 1-72 hours) induces apoptosis and synergizes with chemotherapy in HL-60 cells.
ABT-737 (5, 7.5, 10 μM; 72 hours) causes approximately 80% HCT116 cell death. The BAX knockout variant is completely resistant to ABT-737.
ABT-737 has no effect on cell cycle distribution. ABT-737 disrupts BCL-2/BAX heterodimerization and induces BAX conformational change in HL-60 leukemic cells.
ABT-737 induces a BAX/BAK-dependent impairment of maximal O2 consumption rate in sensitive cells. Stable BCL-2 overexpression in MCF10A cells induces an ABT-737-sensitive primed for death state. ABT-737 induces dose-dependent impairment of maximal O2 consumption rate in B-cell lymphoma cells.
In Vivo: ABT-737 (20, 30 mg/kg/day; i.p.; for 21 days) suppresses the leukemia burden by 48% and 53% at the 20 and 30 mg/kg dose levels, respectively, in four- to six-week-old CB.17 Scid mice with human leukemia KG-1 cells.
ABT-737 significantly extends survival of mice in this aggressive leukemia model.
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | Apoptosis Compound Library | Anti-Cancer Compound Library | Autophagy Compound Library | Peptidomimetic Library | Anti-Aging Compound Library | Anti-Blood Cancer Compound Library | Mitochondria-Targeted Compound Library | Targeted Diversity Library | Protein-protein Interaction Inhibitor Library | Anti-Prostate Cancer Compound Library | Mitochondrial Protection Compound Library | Cell Death Library | SY-5609 | BRD4 Inhibitor-18 | 8α-Tigloyloxyhirsutinolide 13-O-acetate | F1324 | AAPK-25 | Dutasteride-13C6 | Oleic acid-13C | Anticancer agent 120 | Abacavir sulfate | Meloxicam-d3-1 | Thailanstatin D | SB-218078 | Toyocamycin | Sorafenib-d4 | Busulfan | PTC-028 | Dinaciclib | CR-1-31-B | 142I5 | Farudodstat | Ecteinascidin 770 | AT9283 | Staurosporine | SNS-032 | AZA1 | Antitumor agent-96 | Bleomycin A5 | Xevinapant | Mangiferin | Cambinol
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點(diǎn)擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)